IPPOLITI, RODOLFO
 Distribuzione geografica
Continente #
EU - Europa 159
NA - Nord America 155
AS - Asia 34
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 350
Nazione #
US - Stati Uniti d'America 155
IT - Italia 69
IE - Irlanda 38
FR - Francia 19
SE - Svezia 14
CN - Cina 12
IN - India 6
TR - Turchia 6
GB - Regno Unito 5
UA - Ucraina 5
VN - Vietnam 5
DE - Germania 4
BE - Belgio 2
CH - Svizzera 2
TW - Taiwan 2
EG - Egitto 1
EU - Europa 1
FI - Finlandia 1
JP - Giappone 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 350
Città #
Chandler 38
Dublin 38
Chieti 17
Ann Arbor 16
Jacksonville 11
Princeton 10
Ashburn 9
Dearborn 9
Dong Ket 5
Finale Ligure 5
Izmir 5
Altamura 4
Milan 4
Beijing 3
Los Angeles 3
Andover 2
Boardman 2
Brussels 2
Cattolica 2
Civitanova Marche 2
Collecorvino 2
Dübendorf 2
Hebei 2
Leinì 2
Montesilvano Marina 2
Nanjing 2
New York 2
Redwood City 2
San Salvo 2
Seattle 2
Spoltore 2
Taipei 2
Vezzano sul Crostolo 2
Washington 2
Ancona 1
Busso 1
Cairo 1
Cambridge 1
Chicago 1
Cislago 1
Fairfield 1
Fuzhou 1
Gwanak-gu 1
Issy-les-moulineaux 1
Istanbul 1
Kunming 1
Lappeenranta 1
London 1
L’Aquila 1
Norwalk 1
Nuremberg 1
Pune 1
Scafa 1
Shenyang 1
Shizuoka 1
Stockholm 1
Torrevecchia Teatina 1
Vientiane 1
Wilmington 1
Woodbridge 1
Zhengzhou 1
Totale 242
Nome #
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 91
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 88
LGALS3BP antibody-drug-conjugate and its use for the treatment of cancer 56
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 49
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer 47
HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications 29
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 17
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET 13
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 8
Totale 398
Categoria #
all - tutte 1.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 3 6
2019/202062 10 7 1 1 6 5 9 3 5 8 5 2
2020/202149 3 2 2 1 3 11 3 2 4 8 5 5
2021/202233 0 1 2 4 1 1 0 5 3 1 6 9
2022/2023123 10 20 9 7 13 12 4 12 19 4 9 4
2023/2024109 5 4 25 7 12 30 13 6 0 4 3 0
Totale 398